DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC: may contain an incorrect product monograph.
Last updated
Summary
Product
DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| DRAXIMAGE | DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC | DIN 02329786 | Solution | SODIUM IODIDE 131 I, 925 MBq / VIAL | 2508686 to 2508691, 2508697, 2508698, 2508827 to 250833, 2508876, 2508941 to 2508948, 2508969 ,2508975, 2508985, 2508993 to 2508997, 2509126, 2509190,2509202 to 2509205, 2509228 to 2509237, 2509288, 2509359 to 2509364, 2509446, 2509447, 2509432, 2509433 |
Issue
The packaging of the affected lots may contain an incorrect product monograph.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Health Care Establishments.
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Jubilant Draximage Inc. dba Julilant Radiopharma
16751 Autoroute Transcanadienne
Kirkland, Quebec
H9H 3L1
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-77965
Get notified
Receive notifications for new and updated recalls and alerts by category.